Gando, Satoshi
Shiraishi, Atsushi
Abe, Toshikazu
Kushimoto, Shigeki
Mayumi, Toshihiko
Fujishima, Seitaro
Hagiwara, Akiyoshi
Shiino, Yasukazu
Shiraishi, Shin-ichiro
Hifumi, Toru
Otomo, Yasuhiro
Okamoto, Kohji
Sasaki, Junichi
Takuma, Kiyotsugu
Yamakawa, Kazuma
Hoshino, Atsumi
Shiraishi, Atsushi
Abe, Toshiaki
Sugita, Manabu
Hanaki, Yoshihiro
Hagiwara, Akiyoshi
Shiraishi, Shin-ichiro
Shiino, Yasukazu
Harada, Masahiro
Yoshihara, Hideaki
Takuma, Kiyotsugu
Otomo, Yasuhiro
Morino, Kazuma
Shimizu, Yoshihiro
Ishikura, Hiroyasu
Hifumi, Toru
Deguchi, Yoshizumi
Nachi, Sho
Gando, Satoshi
Okamoto, Kohji
Kawakami, Masato
Fujishima, Seitaro
Sasaki, Junichi
Maehara, Junichi
Okada, Kunihiko
Yamakawa, Kazuma
Kiyota, Kazuya
Miki, Yasuo
Koike, Kaoru
Muroya, Takashi
Yamashita, Hisashi
Mayumi, Toshihiko
Anan, Hideaki
Kaneko, Tadashi
Kittaka, Hirotada
Yamaguchi, Hiroyuki
,
Article History
Received: 3 January 2020
Accepted: 14 April 2020
First Online: 15 May 2020
Competing interests
: Gando S reported receiving personal fees from Asahi Kasei Pharma America Inc. and Asahi Kasei Pharma Japan Inc. Shiraishi A reported receiving personal fees from CSL Behring. The other authors have no conflict of interest to declare.